Refine by
Disease Target Articles & Analysis: This-Month
1 articles found
Idiopathic pulmonary fibrosis (IPF) remains a challenging respiratory disease characterized by progressive lung scarring, with current therapies only slowing disease progression. A 2026 study of human and animal models identifies concurrent inhibition of the transcription regulators ID1 and ID3 as a potential therapeutic approach, given their upregulation in ...